Cystic fibrosis and COVID-19: Care considerations
Mirza, Alicia A.
Rad, Elika J.
Mohabir, Paul K.
MetadataShow full item record
The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guidelines. We share a case of a patient with CF and COVID-19 as well as alterations to routine CF care at a large academic center. Key considerations include accessible COVID-19 screening, augmented infection control practices, and rapid integration of telemedicine.
Palabras claveCystic fibrosis; Pulmonary; Covid-19; Infection control
Link to resourcehttps://doi.org/10.1016/j.rmcr.2020.101226
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.